338 related articles for article (PubMed ID: 27188441)
1. BTG1 ameliorates liver steatosis by decreasing stearoyl-CoA desaturase 1 (SCD1) abundance and altering hepatic lipid metabolism.
Xiao F; Deng J; Guo Y; Niu Y; Yuan F; Yu J; Chen S; Guo F
Sci Signal; 2016 May; 9(428):ra50. PubMed ID: 27188441
[TBL] [Abstract][Full Text] [Related]
2. Tangshen formula attenuates hepatic steatosis by inhibiting hepatic lipogenesis and augmenting fatty acid oxidation in db/db mice.
Kong Q; Zhang H; Zhao T; Zhang W; Yan M; Dong X; Li P
Int J Mol Med; 2016 Dec; 38(6):1715-1726. PubMed ID: 27840945
[TBL] [Abstract][Full Text] [Related]
3. Prosteatotic genes are associated with unsaturated fat suppression of saturated fat-induced hepatic steatosis in C57BL/6 mice.
Geng T; Xia L; Russo S; Kamara D; Cowart LA
Nutr Res; 2015 Sep; 35(9):812-22. PubMed ID: 26277244
[TBL] [Abstract][Full Text] [Related]
4. ATF4 deficiency protects mice from high-carbohydrate-diet-induced liver steatosis.
Li H; Meng Q; Xiao F; Chen S; Du Y; Yu J; Wang C; Guo F
Biochem J; 2011 Sep; 438(2):283-9. PubMed ID: 21644928
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of stearoyl-coenzyme A desaturase 1 ameliorates hepatic steatosis by inducing AMPK-mediated lipophagy.
Zhou Y; Zhong L; Yu S; Shen W; Cai C; Yu H
Aging (Albany NY); 2020 Apr; 12(8):7350-7362. PubMed ID: 32324591
[TBL] [Abstract][Full Text] [Related]
6. Hepatic stearoyl CoA desaturase 1 deficiency increases glucose uptake in adipose tissue partially through the PGC-1α-FGF21 axis in mice.
Aljohani A; Khan MI; Bonneville A; Guo C; Jeffery J; O'Neill L; Syed DN; Lewis SA; Burhans M; Mukhtar H; Ntambi JM
J Biol Chem; 2019 Dec; 294(51):19475-19485. PubMed ID: 31690632
[TBL] [Abstract][Full Text] [Related]
7. Sorafenib kills liver cancer cells by disrupting SCD1-mediated synthesis of monounsaturated fatty acids
Liu G; Kuang S; Cao R; Wang J; Peng Q; Sun C
FASEB J; 2019 Sep; 33(9):10089-10103. PubMed ID: 31199678
[TBL] [Abstract][Full Text] [Related]
8. A novel function of B-cell translocation gene 1 (BTG1) in the regulation of hepatic insulin sensitivity in mice via c-Jun.
Xiao F; Deng J; Yu J; Guo Y; Chen S; Guo F
FASEB J; 2016 Jan; 30(1):348-59. PubMed ID: 26396236
[TBL] [Abstract][Full Text] [Related]
9. Hepatic lipid partitioning and liver damage in nonalcoholic fatty liver disease: role of stearoyl-CoA desaturase.
Li ZZ; Berk M; McIntyre TM; Feldstein AE
J Biol Chem; 2009 Feb; 284(9):5637-44. PubMed ID: 19119140
[TBL] [Abstract][Full Text] [Related]
10. Methionine restriction prevents the progression of hepatic steatosis in leptin-deficient obese mice.
Malloy VL; Perrone CE; Mattocks DA; Ables GP; Caliendo NS; Orentreich DS; Orentreich N
Metabolism; 2013 Nov; 62(11):1651-61. PubMed ID: 23928105
[TBL] [Abstract][Full Text] [Related]
11. Reduced adiposity and liver steatosis by stearoyl-CoA desaturase deficiency are independent of peroxisome proliferator-activated receptor-alpha.
Miyazaki M; Dobrzyn A; Sampath H; Lee SH; Man WC; Chu K; Peters JM; Gonzalez FJ; Ntambi JM
J Biol Chem; 2004 Aug; 279(33):35017-24. PubMed ID: 15180999
[TBL] [Abstract][Full Text] [Related]
12. miR-212-5p suppresses lipid accumulation by targeting FAS and SCD1.
Guo Y; Yu J; Wang C; Li K; Liu B; Du Y; Xiao F; Chen S; Guo F
J Mol Endocrinol; 2017 Oct; 59(3):205-217. PubMed ID: 28667176
[TBL] [Abstract][Full Text] [Related]
13. GLP-1 Elicits an Intrinsic Gut-Liver Metabolic Signal to Ameliorate Diet-Induced VLDL Overproduction and Insulin Resistance.
Khound R; Taher J; Baker C; Adeli K; Su Q
Arterioscler Thromb Vasc Biol; 2017 Dec; 37(12):2252-2259. PubMed ID: 29074588
[TBL] [Abstract][Full Text] [Related]
14. TRIF-dependent Toll-like receptor signaling suppresses
Chen J; Li J; Yiu JHC; Lam JKW; Wong CM; Dorweiler B; Xu A; Woo CW
Sci Signal; 2017 Aug; 10(491):. PubMed ID: 28790196
[TBL] [Abstract][Full Text] [Related]
15. Relationships between hepatic stearoyl-CoA desaturase-1 activity and mRNA expression with liver fat content in humans.
Peter A; Cegan A; Wagner S; Elcnerova M; Königsrainer A; Königsrainer I; Häring HU; Schleicher ED; Stefan N
Am J Physiol Endocrinol Metab; 2011 Feb; 300(2):E321-6. PubMed ID: 21045174
[TBL] [Abstract][Full Text] [Related]
16. Long-term fructose consumption prolongs hepatic stearoyl-CoA desaturase 1 activity independent of upstream regulation in rats.
Liu L; Wang S; Yao L; Li JX; Ma P; Jiang LR; Ke DZ; Pan YQ; Wang JW
Biochem Biophys Res Commun; 2016 Oct; 479(4):643-648. PubMed ID: 27697525
[TBL] [Abstract][Full Text] [Related]
17. Stearoyl-CoA desaturase as a new drug target for obesity treatment.
Dobrzyn A; Ntambi JM
Obes Rev; 2005 May; 6(2):169-74. PubMed ID: 15836467
[TBL] [Abstract][Full Text] [Related]
18. Aryl hydrocarbon receptor-mediated induction of Stearoyl-CoA desaturase 1 alters hepatic fatty acid composition in TCDD-elicited steatosis.
Angrish MM; Jones AD; Harkema JR; Zacharewski TR
Toxicol Sci; 2011 Dec; 124(2):299-310. PubMed ID: 21890736
[TBL] [Abstract][Full Text] [Related]
19. CCAAT/enhancer-binding protein beta deletion reduces adiposity, hepatic steatosis, and diabetes in Lepr(db/db) mice.
Schroeder-Gloeckler JM; Rahman SM; Janssen RC; Qiao L; Shao J; Roper M; Fischer SJ; Lowe E; Orlicky DJ; McManaman JL; Palmer C; Gitomer WL; Huang W; O'Doherty RM; Becker TC; Klemm DJ; Jensen DR; Pulawa LK; Eckel RH; Friedman JE
J Biol Chem; 2007 May; 282(21):15717-29. PubMed ID: 17387171
[TBL] [Abstract][Full Text] [Related]
20. SCD1 Expression is dispensable for hepatocarcinogenesis induced by AKT and Ras oncogenes in mice.
Li L; Wang C; Calvisi DF; Evert M; Pilo MG; Jiang L; Yuneva M; Chen X
PLoS One; 2013; 8(9):e75104. PubMed ID: 24069385
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
